Vascular & Endovascular

This channel includes news on non-coronary vascular disease and therapies. These include peripheral artery disease (PAD), abdominal and thoracic aortic aneurysm (AAA and TAA), aortic dissection, pulmonary embolism (PE), critical limb ischemia (CLI), carotid artery and stroke interventions, venous interventions, deep vein thrombosis (DVT), and interventional radiology therapies. The focus on most of these therapies is minimally invasive, catheter-based procedures performed in a cath lab.

hospital ward

How cardiologists can improve in-hospital outcomes after PCI

Researchers evaluated if two recently developed risk scores can anticipate adverse in-hospital outcomes after PCI, sharing their findings in the American Journal of Cardiology.

PCI

A new antiplatelet strategy for treating diabetic PCI patients

Clopidogrel monotherapy after just one month of DAPT was associated with promising outcomes, including a reduction in bleeding events.

How intravascular lithotripsy can improve TMVR outcomes

The IVL technology developed by Shockwave Medical helped clinicians treat a TMVR patient who had previously undergone TAVR. Could this be a common use of IVL in the future?

Medtronic enrolls first patient for head-to-head EVAR study

The randomized trial, expected to enroll at least 550 patients, will follow patients for a total of five years.

Stroke patients with AFib face a higher mortality risk after thrombectomy

A comparative meta-analysis found similar procedural outcomes, but higher 90-day mortality—partially attributable to a higher rate of comorbidities.

AVS Pulse PIVL

Interventional cardiology specialists raise $20M to continue IVL research

AVS, a Michigan-based medical device company, has said the funding will help accelerate research on its new Pulse P-IVL system. One clinical trial is already underway. 

Thumbnail

Black stroke patients hospitalized longer than white patients

Even after adjusting for factors such as income, comorbidities and stroke severity indicators, a prolonged length of stay was more common for Black patients.

Thumbnail

No antithrombotic therapy after TAVR? New research highlights potential benefits

The study, published in JACC: Cardiovascular Interventions, focused on data from more than 3,500 TAVR patients.